Integrated proteomic and metabolomic analysis reveals the potential therapeutic mechanism of Quanduzhong capsule in rats with spontaneous hypertension and knee osteoarthritis

Quanduzhong capsule (QDZ), derived from Eucommia ulmoides Oliv., has been traditionally used in Chinese medicine for its beneficial effects on musculoskeletal health. Its clinical application has extended to conditions such as spontaneous hypertension combined with knee osteoarthritis (SKOA). Howeve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ethnopharmacology 2025-01, Vol.340, p.119176, Article 119176
Hauptverfasser: Ge, Xinyu, Ma, Zhaochen, Wei, Wenjing, Deng, Huaijue, Tang, Shuhui, Han, Yefeng, Li, Yifan, He, Xiaofang, Li, Mingxiao, Lin, Na, Li, Houkai, Zhang, Yanqiong, Sheng, Lili
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 119176
container_title Journal of ethnopharmacology
container_volume 340
creator Ge, Xinyu
Ma, Zhaochen
Wei, Wenjing
Deng, Huaijue
Tang, Shuhui
Han, Yefeng
Li, Yifan
He, Xiaofang
Li, Mingxiao
Lin, Na
Li, Houkai
Zhang, Yanqiong
Sheng, Lili
description Quanduzhong capsule (QDZ), derived from Eucommia ulmoides Oliv., has been traditionally used in Chinese medicine for its beneficial effects on musculoskeletal health. Its clinical application has extended to conditions such as spontaneous hypertension combined with knee osteoarthritis (SKOA). However, the specific mechanisms by which QDZ alleviates symptoms and improves outcomes in this complex condition remain to be fully elucidated. This study aims to evaluate the therapeutic potential of QDZ in treating SKOA. By performing serum proteomics and metabolomics, we seek to explore the related biological pathways and elucidate the mechanisms underlying QDZ's effects on SKOA. Serum samples from control, spontaneous hypertension (SHR), SKOA, and SKOA treated with QDZ groups were analyzed using data-independent acquisition-based proteomics to identify differentially expressed proteins. Serum levels of angiotensin II, norepinephrine, endothelin-1, classical pro-inflammatory factors such as macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interleukin-1 beta were measured. Additionally, serum metabolomics was performed to examine the changes in metabolite profiles. Correlation analysis was conducted to link changed proteins and metabolites with key pathways affected by QDZ. Proteomics analysis revealed significant alterations in serum protein expression between control, SHR, and SKOA groups, with changes in pathways related to immune regulation and vascular function. KEGG enrichment analysis highlighted pathways such as endocytosis, synaptic vesicle cycling, and immune responses were enriched in SKOA group compared with control group. QDZ treatment significantly modulated above pathways and reduced inflammatory and cardiovascular markers which were upregulated in SKOA group. Metabolomics analysis showed that QDZ reversed SKOA-induced changes in amino acid and organic acid metabolism, affecting pathways including valine, leucine, and isoleucine metabolism, as well as the TCA cycle. Correlation analysis revealed significant relationships between key proteins and metabolites, underscoring the integrated role of immune and metabolic pathways in QDZ's effects. Our results indicate QDZ has a significant therapeutic potential for SKOA by modulating both protein and metabolite profiles associated with inflammation, vascular dysfunction, and metabolic imbalance. Our findings provide insights into the mechanisms through which QDZ exerts its effects and
doi_str_mv 10.1016/j.jep.2024.119176
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3154258298</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378874124014752</els_id><sourcerecordid>3154258298</sourcerecordid><originalsourceid>FETCH-LOGICAL-c268t-37f46e61c988a31580cb2029fa3b525732a744483c98406f5a97b345d596f81f3</originalsourceid><addsrcrecordid>eNqNkUGL1TAUhYMoznP0B7iRLN30mTRpkuJKBp0ZGBBB1yFNb6d5tklN0pHnj_I3mmefLsXV5cJ3zz2cg9BLSvaUUPHmsD_Asq9JzfeUtlSKR2hHlawr2Uj2GO0Ik6pSktML9CylAyFEUk6eogvWCiqJanfo563PcB9Nhh4vMWQIs7PY-B7PkE0XpvNupmNyCUd4ADMlnEfAS6F9dmY6bdEssOaCzmBH412acRjwp7UorT_G4O-xNUtaJ8DO4_Iu4e8ujzgtwWfjIawJj8cFYpFMLvjfDr56ABxS8WRiHqPLLj1HT4byH16c5yX68uH956ub6u7j9e3Vu7vK1kLlismBCxDUtkoZRhtFbFdiagfDuqYu4dRGcs4VKwAnYmhMKzvGm75pxaDowC7R6023ZPJthZT17JKFadq86qLJ60bVrfoPlJekGeeioHRDbQwpRRj0Et1s4lFTok-N6oMujepTo3prtNy8Osuv3Qz934s_FRbg7QZAyePBQdTJOvAWehfBZt0H9w_5X0crtXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3140893446</pqid></control><display><type>article</type><title>Integrated proteomic and metabolomic analysis reveals the potential therapeutic mechanism of Quanduzhong capsule in rats with spontaneous hypertension and knee osteoarthritis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ge, Xinyu ; Ma, Zhaochen ; Wei, Wenjing ; Deng, Huaijue ; Tang, Shuhui ; Han, Yefeng ; Li, Yifan ; He, Xiaofang ; Li, Mingxiao ; Lin, Na ; Li, Houkai ; Zhang, Yanqiong ; Sheng, Lili</creator><creatorcontrib>Ge, Xinyu ; Ma, Zhaochen ; Wei, Wenjing ; Deng, Huaijue ; Tang, Shuhui ; Han, Yefeng ; Li, Yifan ; He, Xiaofang ; Li, Mingxiao ; Lin, Na ; Li, Houkai ; Zhang, Yanqiong ; Sheng, Lili</creatorcontrib><description>Quanduzhong capsule (QDZ), derived from Eucommia ulmoides Oliv., has been traditionally used in Chinese medicine for its beneficial effects on musculoskeletal health. Its clinical application has extended to conditions such as spontaneous hypertension combined with knee osteoarthritis (SKOA). However, the specific mechanisms by which QDZ alleviates symptoms and improves outcomes in this complex condition remain to be fully elucidated. This study aims to evaluate the therapeutic potential of QDZ in treating SKOA. By performing serum proteomics and metabolomics, we seek to explore the related biological pathways and elucidate the mechanisms underlying QDZ's effects on SKOA. Serum samples from control, spontaneous hypertension (SHR), SKOA, and SKOA treated with QDZ groups were analyzed using data-independent acquisition-based proteomics to identify differentially expressed proteins. Serum levels of angiotensin II, norepinephrine, endothelin-1, classical pro-inflammatory factors such as macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interleukin-1 beta were measured. Additionally, serum metabolomics was performed to examine the changes in metabolite profiles. Correlation analysis was conducted to link changed proteins and metabolites with key pathways affected by QDZ. Proteomics analysis revealed significant alterations in serum protein expression between control, SHR, and SKOA groups, with changes in pathways related to immune regulation and vascular function. KEGG enrichment analysis highlighted pathways such as endocytosis, synaptic vesicle cycling, and immune responses were enriched in SKOA group compared with control group. QDZ treatment significantly modulated above pathways and reduced inflammatory and cardiovascular markers which were upregulated in SKOA group. Metabolomics analysis showed that QDZ reversed SKOA-induced changes in amino acid and organic acid metabolism, affecting pathways including valine, leucine, and isoleucine metabolism, as well as the TCA cycle. Correlation analysis revealed significant relationships between key proteins and metabolites, underscoring the integrated role of immune and metabolic pathways in QDZ's effects. Our results indicate QDZ has a significant therapeutic potential for SKOA by modulating both protein and metabolite profiles associated with inflammation, vascular dysfunction, and metabolic imbalance. Our findings provide insights into the mechanisms through which QDZ exerts its effects and support its use as a promising treatment for SKOA. This study highlights the impact of QDZ on proteomic and metabolomic alterations, offering a basis for its broader application in treating SKOA. [Display omitted] •Quanduzhong capsule (QDZ) effectively attenuates spontaneous hypertension combined with knee osteoarthritis in rats.•QDZ treatment regulates the expression of immune response and vascular function related proteins.•Metabolomics analysis reveals the reversed effect of QDZ in amino acid and organic acid metabolism.•Comprehensive analysis uncovers close interaction between functional proteins and metabolites after QDZ intervention.</description><identifier>ISSN: 0378-8741</identifier><identifier>ISSN: 1872-7573</identifier><identifier>EISSN: 1872-7573</identifier><identifier>DOI: 10.1016/j.jep.2024.119176</identifier><identifier>PMID: 39617089</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Animals ; blood proteins ; blood serum ; Disease Models, Animal ; Drugs, Chinese Herbal - pharmacology ; Drugs, Chinese Herbal - therapeutic use ; endocytosis ; endothelins ; Eucommia ulmoides ; gene expression regulation ; hypertension ; Hypertension - drug therapy ; inflammation ; interleukin-1beta ; isoleucine ; Knee osteoarthritis ; leucine ; macrophage colony-stimulating factor ; Male ; metabolites ; Metabolomics ; musculoskeletal system ; norepinephrine ; Oriental traditional medicine ; osteoarthritis ; Osteoarthritis, Knee - drug therapy ; Osteoarthritis, Knee - metabolism ; protein synthesis ; Proteomics ; Quanduzhong capsule ; Rats ; Rats, Inbred SHR ; Rats, Sprague-Dawley ; Spontaneous hypertension ; synaptic vesicles ; therapeutics ; tricarboxylic acid cycle ; tumor necrosis factor-alpha ; valine</subject><ispartof>Journal of ethnopharmacology, 2025-01, Vol.340, p.119176, Article 119176</ispartof><rights>2024 Elsevier B.V.</rights><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c268t-37f46e61c988a31580cb2029fa3b525732a744483c98406f5a97b345d596f81f3</cites><orcidid>0000-0002-1142-6512</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378874124014752$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39617089$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ge, Xinyu</creatorcontrib><creatorcontrib>Ma, Zhaochen</creatorcontrib><creatorcontrib>Wei, Wenjing</creatorcontrib><creatorcontrib>Deng, Huaijue</creatorcontrib><creatorcontrib>Tang, Shuhui</creatorcontrib><creatorcontrib>Han, Yefeng</creatorcontrib><creatorcontrib>Li, Yifan</creatorcontrib><creatorcontrib>He, Xiaofang</creatorcontrib><creatorcontrib>Li, Mingxiao</creatorcontrib><creatorcontrib>Lin, Na</creatorcontrib><creatorcontrib>Li, Houkai</creatorcontrib><creatorcontrib>Zhang, Yanqiong</creatorcontrib><creatorcontrib>Sheng, Lili</creatorcontrib><title>Integrated proteomic and metabolomic analysis reveals the potential therapeutic mechanism of Quanduzhong capsule in rats with spontaneous hypertension and knee osteoarthritis</title><title>Journal of ethnopharmacology</title><addtitle>J Ethnopharmacol</addtitle><description>Quanduzhong capsule (QDZ), derived from Eucommia ulmoides Oliv., has been traditionally used in Chinese medicine for its beneficial effects on musculoskeletal health. Its clinical application has extended to conditions such as spontaneous hypertension combined with knee osteoarthritis (SKOA). However, the specific mechanisms by which QDZ alleviates symptoms and improves outcomes in this complex condition remain to be fully elucidated. This study aims to evaluate the therapeutic potential of QDZ in treating SKOA. By performing serum proteomics and metabolomics, we seek to explore the related biological pathways and elucidate the mechanisms underlying QDZ's effects on SKOA. Serum samples from control, spontaneous hypertension (SHR), SKOA, and SKOA treated with QDZ groups were analyzed using data-independent acquisition-based proteomics to identify differentially expressed proteins. Serum levels of angiotensin II, norepinephrine, endothelin-1, classical pro-inflammatory factors such as macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interleukin-1 beta were measured. Additionally, serum metabolomics was performed to examine the changes in metabolite profiles. Correlation analysis was conducted to link changed proteins and metabolites with key pathways affected by QDZ. Proteomics analysis revealed significant alterations in serum protein expression between control, SHR, and SKOA groups, with changes in pathways related to immune regulation and vascular function. KEGG enrichment analysis highlighted pathways such as endocytosis, synaptic vesicle cycling, and immune responses were enriched in SKOA group compared with control group. QDZ treatment significantly modulated above pathways and reduced inflammatory and cardiovascular markers which were upregulated in SKOA group. Metabolomics analysis showed that QDZ reversed SKOA-induced changes in amino acid and organic acid metabolism, affecting pathways including valine, leucine, and isoleucine metabolism, as well as the TCA cycle. Correlation analysis revealed significant relationships between key proteins and metabolites, underscoring the integrated role of immune and metabolic pathways in QDZ's effects. Our results indicate QDZ has a significant therapeutic potential for SKOA by modulating both protein and metabolite profiles associated with inflammation, vascular dysfunction, and metabolic imbalance. Our findings provide insights into the mechanisms through which QDZ exerts its effects and support its use as a promising treatment for SKOA. This study highlights the impact of QDZ on proteomic and metabolomic alterations, offering a basis for its broader application in treating SKOA. [Display omitted] •Quanduzhong capsule (QDZ) effectively attenuates spontaneous hypertension combined with knee osteoarthritis in rats.•QDZ treatment regulates the expression of immune response and vascular function related proteins.•Metabolomics analysis reveals the reversed effect of QDZ in amino acid and organic acid metabolism.•Comprehensive analysis uncovers close interaction between functional proteins and metabolites after QDZ intervention.</description><subject>Animals</subject><subject>blood proteins</subject><subject>blood serum</subject><subject>Disease Models, Animal</subject><subject>Drugs, Chinese Herbal - pharmacology</subject><subject>Drugs, Chinese Herbal - therapeutic use</subject><subject>endocytosis</subject><subject>endothelins</subject><subject>Eucommia ulmoides</subject><subject>gene expression regulation</subject><subject>hypertension</subject><subject>Hypertension - drug therapy</subject><subject>inflammation</subject><subject>interleukin-1beta</subject><subject>isoleucine</subject><subject>Knee osteoarthritis</subject><subject>leucine</subject><subject>macrophage colony-stimulating factor</subject><subject>Male</subject><subject>metabolites</subject><subject>Metabolomics</subject><subject>musculoskeletal system</subject><subject>norepinephrine</subject><subject>Oriental traditional medicine</subject><subject>osteoarthritis</subject><subject>Osteoarthritis, Knee - drug therapy</subject><subject>Osteoarthritis, Knee - metabolism</subject><subject>protein synthesis</subject><subject>Proteomics</subject><subject>Quanduzhong capsule</subject><subject>Rats</subject><subject>Rats, Inbred SHR</subject><subject>Rats, Sprague-Dawley</subject><subject>Spontaneous hypertension</subject><subject>synaptic vesicles</subject><subject>therapeutics</subject><subject>tricarboxylic acid cycle</subject><subject>tumor necrosis factor-alpha</subject><subject>valine</subject><issn>0378-8741</issn><issn>1872-7573</issn><issn>1872-7573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUGL1TAUhYMoznP0B7iRLN30mTRpkuJKBp0ZGBBB1yFNb6d5tklN0pHnj_I3mmefLsXV5cJ3zz2cg9BLSvaUUPHmsD_Asq9JzfeUtlSKR2hHlawr2Uj2GO0Ik6pSktML9CylAyFEUk6eogvWCiqJanfo563PcB9Nhh4vMWQIs7PY-B7PkE0XpvNupmNyCUd4ADMlnEfAS6F9dmY6bdEssOaCzmBH412acRjwp7UorT_G4O-xNUtaJ8DO4_Iu4e8ujzgtwWfjIawJj8cFYpFMLvjfDr56ABxS8WRiHqPLLj1HT4byH16c5yX68uH956ub6u7j9e3Vu7vK1kLlismBCxDUtkoZRhtFbFdiagfDuqYu4dRGcs4VKwAnYmhMKzvGm75pxaDowC7R6023ZPJthZT17JKFadq86qLJ60bVrfoPlJekGeeioHRDbQwpRRj0Et1s4lFTok-N6oMujepTo3prtNy8Osuv3Qz934s_FRbg7QZAyePBQdTJOvAWehfBZt0H9w_5X0crtXg</recordid><startdate>20250131</startdate><enddate>20250131</enddate><creator>Ge, Xinyu</creator><creator>Ma, Zhaochen</creator><creator>Wei, Wenjing</creator><creator>Deng, Huaijue</creator><creator>Tang, Shuhui</creator><creator>Han, Yefeng</creator><creator>Li, Yifan</creator><creator>He, Xiaofang</creator><creator>Li, Mingxiao</creator><creator>Lin, Na</creator><creator>Li, Houkai</creator><creator>Zhang, Yanqiong</creator><creator>Sheng, Lili</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0002-1142-6512</orcidid></search><sort><creationdate>20250131</creationdate><title>Integrated proteomic and metabolomic analysis reveals the potential therapeutic mechanism of Quanduzhong capsule in rats with spontaneous hypertension and knee osteoarthritis</title><author>Ge, Xinyu ; Ma, Zhaochen ; Wei, Wenjing ; Deng, Huaijue ; Tang, Shuhui ; Han, Yefeng ; Li, Yifan ; He, Xiaofang ; Li, Mingxiao ; Lin, Na ; Li, Houkai ; Zhang, Yanqiong ; Sheng, Lili</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c268t-37f46e61c988a31580cb2029fa3b525732a744483c98406f5a97b345d596f81f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Animals</topic><topic>blood proteins</topic><topic>blood serum</topic><topic>Disease Models, Animal</topic><topic>Drugs, Chinese Herbal - pharmacology</topic><topic>Drugs, Chinese Herbal - therapeutic use</topic><topic>endocytosis</topic><topic>endothelins</topic><topic>Eucommia ulmoides</topic><topic>gene expression regulation</topic><topic>hypertension</topic><topic>Hypertension - drug therapy</topic><topic>inflammation</topic><topic>interleukin-1beta</topic><topic>isoleucine</topic><topic>Knee osteoarthritis</topic><topic>leucine</topic><topic>macrophage colony-stimulating factor</topic><topic>Male</topic><topic>metabolites</topic><topic>Metabolomics</topic><topic>musculoskeletal system</topic><topic>norepinephrine</topic><topic>Oriental traditional medicine</topic><topic>osteoarthritis</topic><topic>Osteoarthritis, Knee - drug therapy</topic><topic>Osteoarthritis, Knee - metabolism</topic><topic>protein synthesis</topic><topic>Proteomics</topic><topic>Quanduzhong capsule</topic><topic>Rats</topic><topic>Rats, Inbred SHR</topic><topic>Rats, Sprague-Dawley</topic><topic>Spontaneous hypertension</topic><topic>synaptic vesicles</topic><topic>therapeutics</topic><topic>tricarboxylic acid cycle</topic><topic>tumor necrosis factor-alpha</topic><topic>valine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ge, Xinyu</creatorcontrib><creatorcontrib>Ma, Zhaochen</creatorcontrib><creatorcontrib>Wei, Wenjing</creatorcontrib><creatorcontrib>Deng, Huaijue</creatorcontrib><creatorcontrib>Tang, Shuhui</creatorcontrib><creatorcontrib>Han, Yefeng</creatorcontrib><creatorcontrib>Li, Yifan</creatorcontrib><creatorcontrib>He, Xiaofang</creatorcontrib><creatorcontrib>Li, Mingxiao</creatorcontrib><creatorcontrib>Lin, Na</creatorcontrib><creatorcontrib>Li, Houkai</creatorcontrib><creatorcontrib>Zhang, Yanqiong</creatorcontrib><creatorcontrib>Sheng, Lili</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Journal of ethnopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ge, Xinyu</au><au>Ma, Zhaochen</au><au>Wei, Wenjing</au><au>Deng, Huaijue</au><au>Tang, Shuhui</au><au>Han, Yefeng</au><au>Li, Yifan</au><au>He, Xiaofang</au><au>Li, Mingxiao</au><au>Lin, Na</au><au>Li, Houkai</au><au>Zhang, Yanqiong</au><au>Sheng, Lili</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrated proteomic and metabolomic analysis reveals the potential therapeutic mechanism of Quanduzhong capsule in rats with spontaneous hypertension and knee osteoarthritis</atitle><jtitle>Journal of ethnopharmacology</jtitle><addtitle>J Ethnopharmacol</addtitle><date>2025-01-31</date><risdate>2025</risdate><volume>340</volume><spage>119176</spage><pages>119176-</pages><artnum>119176</artnum><issn>0378-8741</issn><issn>1872-7573</issn><eissn>1872-7573</eissn><abstract>Quanduzhong capsule (QDZ), derived from Eucommia ulmoides Oliv., has been traditionally used in Chinese medicine for its beneficial effects on musculoskeletal health. Its clinical application has extended to conditions such as spontaneous hypertension combined with knee osteoarthritis (SKOA). However, the specific mechanisms by which QDZ alleviates symptoms and improves outcomes in this complex condition remain to be fully elucidated. This study aims to evaluate the therapeutic potential of QDZ in treating SKOA. By performing serum proteomics and metabolomics, we seek to explore the related biological pathways and elucidate the mechanisms underlying QDZ's effects on SKOA. Serum samples from control, spontaneous hypertension (SHR), SKOA, and SKOA treated with QDZ groups were analyzed using data-independent acquisition-based proteomics to identify differentially expressed proteins. Serum levels of angiotensin II, norepinephrine, endothelin-1, classical pro-inflammatory factors such as macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interleukin-1 beta were measured. Additionally, serum metabolomics was performed to examine the changes in metabolite profiles. Correlation analysis was conducted to link changed proteins and metabolites with key pathways affected by QDZ. Proteomics analysis revealed significant alterations in serum protein expression between control, SHR, and SKOA groups, with changes in pathways related to immune regulation and vascular function. KEGG enrichment analysis highlighted pathways such as endocytosis, synaptic vesicle cycling, and immune responses were enriched in SKOA group compared with control group. QDZ treatment significantly modulated above pathways and reduced inflammatory and cardiovascular markers which were upregulated in SKOA group. Metabolomics analysis showed that QDZ reversed SKOA-induced changes in amino acid and organic acid metabolism, affecting pathways including valine, leucine, and isoleucine metabolism, as well as the TCA cycle. Correlation analysis revealed significant relationships between key proteins and metabolites, underscoring the integrated role of immune and metabolic pathways in QDZ's effects. Our results indicate QDZ has a significant therapeutic potential for SKOA by modulating both protein and metabolite profiles associated with inflammation, vascular dysfunction, and metabolic imbalance. Our findings provide insights into the mechanisms through which QDZ exerts its effects and support its use as a promising treatment for SKOA. This study highlights the impact of QDZ on proteomic and metabolomic alterations, offering a basis for its broader application in treating SKOA. [Display omitted] •Quanduzhong capsule (QDZ) effectively attenuates spontaneous hypertension combined with knee osteoarthritis in rats.•QDZ treatment regulates the expression of immune response and vascular function related proteins.•Metabolomics analysis reveals the reversed effect of QDZ in amino acid and organic acid metabolism.•Comprehensive analysis uncovers close interaction between functional proteins and metabolites after QDZ intervention.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>39617089</pmid><doi>10.1016/j.jep.2024.119176</doi><orcidid>https://orcid.org/0000-0002-1142-6512</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0378-8741
ispartof Journal of ethnopharmacology, 2025-01, Vol.340, p.119176, Article 119176
issn 0378-8741
1872-7573
1872-7573
language eng
recordid cdi_proquest_miscellaneous_3154258298
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
blood proteins
blood serum
Disease Models, Animal
Drugs, Chinese Herbal - pharmacology
Drugs, Chinese Herbal - therapeutic use
endocytosis
endothelins
Eucommia ulmoides
gene expression regulation
hypertension
Hypertension - drug therapy
inflammation
interleukin-1beta
isoleucine
Knee osteoarthritis
leucine
macrophage colony-stimulating factor
Male
metabolites
Metabolomics
musculoskeletal system
norepinephrine
Oriental traditional medicine
osteoarthritis
Osteoarthritis, Knee - drug therapy
Osteoarthritis, Knee - metabolism
protein synthesis
Proteomics
Quanduzhong capsule
Rats
Rats, Inbred SHR
Rats, Sprague-Dawley
Spontaneous hypertension
synaptic vesicles
therapeutics
tricarboxylic acid cycle
tumor necrosis factor-alpha
valine
title Integrated proteomic and metabolomic analysis reveals the potential therapeutic mechanism of Quanduzhong capsule in rats with spontaneous hypertension and knee osteoarthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T18%3A14%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrated%20proteomic%20and%20metabolomic%20analysis%20reveals%20the%20potential%20therapeutic%20mechanism%20of%20Quanduzhong%20capsule%20in%20rats%20with%20spontaneous%20hypertension%20and%20knee%20osteoarthritis&rft.jtitle=Journal%20of%20ethnopharmacology&rft.au=Ge,%20Xinyu&rft.date=2025-01-31&rft.volume=340&rft.spage=119176&rft.pages=119176-&rft.artnum=119176&rft.issn=0378-8741&rft.eissn=1872-7573&rft_id=info:doi/10.1016/j.jep.2024.119176&rft_dat=%3Cproquest_cross%3E3154258298%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3140893446&rft_id=info:pmid/39617089&rft_els_id=S0378874124014752&rfr_iscdi=true